Skip to main content
v2026.11,986 entries · CC-BY 4.0
CASRAIAsk CASRAI · AI assistant for researchAsk a research question. Answers come with their sources.Funder rules, compliance, methods and publishing. Answers link the sources they rest on.

Editorial · CASRAI · AI and ML research outputs

Apple launches AI health study with up to 200,000 adults

Apple and OpenEvidence launch a U.S. study of how up to 200,000 adults understand, trust and use conversational health AI.

Published 16 Nov 2026· 5 minute read

Ask CASRAI · free to try

Ask about this story

2 free questions a day, no account.

An AI assistant for research: funder rules, compliance, methods and publishing. It links the sources behind its answers and labels answers that come from a web search.

Answers draw on CASRAI's guides and dictionary plus the federal and funder documents we index: Federal Register, Grants.gov, Regulations.gov and UKRI.

Works on this site and inside Claude, Cursor and the AI tools you already use.

Everything CASRAI publishes — this page, the dictionary, the guides and the news — stays open to read, with no account and no card.

CASRAI is the reference for research administration — bookmark it for the next question.

Apple launched the Apple Health AI Usage Study in the United States on November 15, 2026, working with OpenEvidence to examine how people understand and use conversational health AI. The company plans to enroll up to 200,000 adults. For researchers and universities, the central question is whether medically grounded answers translate into comprehension, appropriate trust and useful preparation for clinical conversations.

What Apple announced

In its launch announcement, Apple described a virtual study conducted through a dedicated app. It will examine response quality, user trust, comprehension and everyday health actions. These are research objectives, rather than findings from a completed evaluation.

Apple says OpenEvidence supplies medically grounded AI technology while Apple provides the research experience. Responses will include links to peer-reviewed clinical citations. The announcement names The New England Journal of Medicine, the Journal of the American Medical Association and Nature among the medical information sources used by OpenEvidence.

The distinction matters for research communication: an answer can cite medical literature while its effect on the person reading it remains an empirical question. Apple’s stated study objectives encompass both the information delivered and the participant’s understanding of that information.

What participation will measure

CNET’s account of Apple’s press briefing describes a baseline survey, monthly surveys and additional questionnaires about preparation for medical appointments. Participants can rate individual responses and explain what worked or could improve. CNET reports that participants are asked to take part for up to 12 months.

Those measures separate several questions that are often collapsed into a single claim about an AI tool being helpful. A response rating records the participant’s assessment of an answer. A survey about a later appointment examines a different part of the experience. Neither alone establishes that a system improves clinical outcomes; the announced project is investigating engagement and understanding.

CNET also reports that demographic information collected during onboarding will help examine differences in preferences and communication needs. That gives university teams a concrete issue to follow when results emerge: whether findings are reported across participant groups, rather than only as an overall satisfaction score.

Eligibility limits the population

Apple’s announcement specifies U.S. participants age 21 and older with an Apple Intelligence-enabled iPhone, identified as iPhone 15 Pro or later, running iOS 26 or later. Its target is up to 200,000 eligible participants. That is an enrollment ceiling, rather than a count of people already recruited or retained.

For researchers interpreting eventual findings, those device, age and geographic requirements define the population being studied. A large recruitment target would not by itself make results representative of younger people, people outside the United States or users of other devices. Comparisons with other populations would need evidence beyond the announced recruitment framework.

The App Store listing describes the app as a way to contribute to research and explicitly says neither the app nor the study provides medical advice, diagnosis or treatment. Its store age rating of 18+ should not be confused with the study’s announced minimum enrollment age of 21.

Optional health data and privacy commitments

Apple says participants can choose whether to share HealthKit information, including activity, sleep, resting heart rate or laboratory results, to explore whether personal context changes relevance and understanding. The company also says study data will not be used to train AI models and that participants control whether to share survey responses and HealthKit metrics.

ABC News reports that Apple says identifying information is removed through privacy protections before questions reach OpenEvidence. According to Apple’s statements to the outlet, OpenEvidence deletes question-and-response data within 24 hours. These are attributed descriptions of the study’s safeguards, rather than an independent privacy audit.

For research offices, optional data sharing makes the informed consent process especially relevant: participation, disclosure of existing health information and evaluation of generated responses are distinct activities. The design provides a specific case for examining how participants understand those choices in a digital research setting.

Researchers emphasize understanding alongside accuracy

ABC News contributor John Brownstein, a Harvard Medical School professor of pediatrics and biomedical informatics, told the outlet that accurate answers can still be confusing or incomplete. He emphasized the need to examine whether people understand answers, trust them appropriately and make better decisions.

In Apple’s announcement, UCSF Department of Medicine chair Robert M. Wachter similarly argued for studying how patients and clinicians can use trustworthy tools together. His comments describe the intended value of connecting those experiences; they do not establish that the new study has already demonstrated such benefits.

For university teams developing similar systems, the practical implication is to evaluate user interpretation alongside answer quality. CASRAI’s background on AI for research compliance explains the wider governance context, while the institutional review board entry explains the oversight role relevant to human-participant research. Neither establishes any specific oversight determination for Apple’s project.

What happens next

The app is available and recruitment is beginning. CNET reports that no publication date has been set. ABC News says Apple intends to make the research broadly available to inform computer-assisted health communication. The next substantive evidence will therefore be enrollment, study reporting and eventual results, rather than the launch itself establishing effectiveness.

Sources

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →